Ftse Mib
33.629,21
-0,32%
DAX
18.001,60
0,54%
S&P 500
5.127,79
1,26%
NASDAQ
16.156,33
1,99%
Bitcoin
63.801,70
1,44%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Ekso Bionics Holdings Inc (EKSO) Ekso Bionics Holdings Inc (EKSO) Notizie

Ekso Bionics Holdings Inc

EKSO
1,31
0,02 (1,55%)
04 Mag 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
29/4/202422:05GLOBEEkso Bionics Announces First Quarter 2024 Financial Results
22/4/202414:00GLOBEEkso Bionics to Report First Quarter 2024 Financial Results..
12/4/202414:00GLOBEEkso Bionics Receives Final Payment Determination for..
04/3/202422:14EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
04/3/202422:08EDGAR2Form 8-K - Current report
04/3/202422:05GLOBEEkso Bionics Reports Record Annual Revenue of $18.3 Million
26/2/202414:00GLOBEEkso Bionics to Report Fourth Quarter and Full Year 2023..
16/1/202418:16EDGAR2Form 8-K - Current report
11/1/202414:00GLOBEEkso Bionics Announces $4.6 Million Registered Direct..
10/1/202423:23EDGAR2Form 8-K - Current report
08/1/202422:05GLOBEEkso Bionics Launches GaitCoach Software for EksoNR
04/1/202423:05GLOBEEkso Bionics Reports Certain Preliminary Fourth Quarter and..
12/12/202314:00GLOBEEkso Bionics Receives CMS Coding Approval for Ekso Indego..
16/11/202322:05GLOBEEkso Bionics to Participate at Centers for Medicare &..
14/11/202322:13EDGAR2Form 8-K - Current report
02/11/202321:01GLOBECenters for Medicare & Medicaid Services (CMS) Codifies..
26/10/202322:17EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
26/10/202322:10EDGAR2Form 8-K - Current report
26/10/202322:05GLOBEEkso Bionics Reports Third Quarter 2023 Revenue Growth of..
19/10/202322:05GLOBEEkso Bionics to Report Third Quarter 2023 Financial Results..
29/9/202323:23EDGAR2Form 8-K - Current report
27/9/202314:00GLOBEEkso Bionics Supports Centers for Medicare & Medicaid..
11/9/202314:00GLOBEEkso Bionics to Participate at the H.C. Wainwright 25th..
19/8/202303:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/8/202303:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/8/202322:29EDGAR2Form 8-K - Current report
28/7/202315:28EDGAR2Form 8-K - Current report
28/7/202315:28EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
27/7/202322:11EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
27/7/202322:08EDGAR2Form 8-K - Current report
27/7/202322:05GLOBEEkso Bionics Reports Record Revenues of $4.7 Million in..
20/7/202314:00GLOBEEkso Bionics to Report Second Quarter 2023 Financial..
Apertura: 1,30 Min: 1,27 Max: 1,33
Chiusura: 1,29

La tua Cronologia

NASDAQ
EKSO
Ekso Bionics
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network